Search results: returned 256 results

Butylparaben (CAS No. 94-26-8, EC No. 202-318-7) with the chemical name ‘Butyl 4-hydroxybenzoate’ is currently regulated as a preservative (Annex V entry 12a) in a concentration up to 0.14 % (as acid) when used on its own or for the sum of its combined use with propyl paraben and its salts (Anne...

In light of the data provided and taking under consideration the concerns related to potential endocrine disrupting properties of Benzyl Salicylate, does the SCCS consider Benzyl Salicylate safe when used up to the maximum concentrations provided in the dossier submission by the Benzyl Salicylat...

Developments in the field of nanotechnology have opened up new prospects for innovation in cosmetics. At the same time, the use of very small particles in consumer products has raised concerns over their safety to human health and the environment (Borm et al., 2006; Fadeel et al., 2017; Wu and T...

Having assessed the information provided by the Notifiers, and the information available from published literature, the SCCS cannot conclude on the safety of fullerenes and (hydrated) hydroxylated forms of fullerenes due to a number of uncertainties and data gaps in regard to physicochemical, to...

1. In light of the data provided, does the SCCS consider HC Blue 18, safe when used in non-oxidative as well as in oxidative hair dye formulations up to a maximum on-head concentration of 0.35 %? In light of the new physicochemical data provided, SCCS considers that the use of HC Blue 18 as an i...

The SCCS concludes the following: In light of the information submitted via the call for data, the currently available scientific literature, relevant in silico tools and SCCS’ expert judgement and taking under consideration in particular the concerns related to potential endocrine disrupting pr...

In light of the data provided, does the SCCS consider Isopropyl cloprostenate (CAS 157283-66-4) and Ethyl Tafluprostamide or DDDE (CAS 1185851-52-8) safe when used up to the concentrations provided in the respective dossiers (0.006% and 0.007% for Isopropyl cloprostenate and 0.018% for Ethyl Taf...

The SCCS concludes the following: 1. In light of the data provided and taking under consideration the concerns related to potential endocrine disrupting properties of 4-Methylbenzylidene camphor (4-MBC), does the SCCS consider 4-MBC safe when used as a UV-filter in cosmetic products up to a maxi...

The SCCS concludes the following: 1. In light of the data provided and taking under consideration the concerns related to potential endocrine disrupting properties of Kojic acid, does the SCCS consider Kojic acid safe when used in cosmetic products up to a maximum concentration of 1 %? On the ba...

The SCCS concludes the following: 1. In light of the data provided, does the SCCS consider that the contribution of the cosmetic products among the overall/total exposure to vitamin A is of concern? The SCCS is of the opinion that vitamin A in cosmetics at the concentrations of 0.05% Retinol Equ...